Semaglutide

Semaglutide

$375

Semaglutide's effectiveness in weight management has been demonstrated in numerous clinical trials, showcasing its potential beyond diabetes treatment. By targeting the GLP-1 receptors, it not only aids in reducing hunger but also enhances the feeling of fullness after meals. This dual action makes it a promising option for individuals struggling with obesity or those needing to manage their weight for health reasons.

Key Benefits

  • Clinically proven weight loss (average 15–20% in clinical trials)
  • Reduced hunger and increased feeling of fullness
  • Improved blood sugar control
  • Potential reduction in cardiovascular risk factors
  • Once-weekly convenient dosing

Semaglutide   is   a   GLP-1   (glucagon-like   peptide-1)   receptor   agonist   that   helps   regulate   appetite,   food   intake,   and   blood   sugar   control.   Originally   developed   for   type   2   diabetes,   it   has   gained   recognition   for   supporting   sustainable   weight   loss   through   its   actions   on   appetite   centers   in   the   brain   and   digestive   processes.

Semaglutide

Who Can Benefit from Semaglutide?

Semaglutide is indicated for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition, as well as those with type 2 diabetes requiring improved glycemic control.

1

Excess weight or obesity

For individuals with a BMI over 30, or over 27 with weight-related complications, semaglutide offers a medical approach to weight management that addresses underlying hormonal factors affecting appetite regulation and metabolism.

2

Difficulty controlling appetite or food cravings

Many patients struggle with persistent hunger and food cravings that sabotage weight loss efforts. Semaglutide helps regulate these sensations by acting on appetite centers in the brain, making consistent calorie reduction more sustainable.

3

Weight-related health conditions

Conditions like high blood pressure, sleep apnea, osteoarthritis, and fatty liver disease often improve with weight loss. Semaglutide can be particularly beneficial for patients where weight management is part of treating these conditions.

4

Type 2 diabetes

For patients with type 2 diabetes, semaglutide offers dual benefits of improved glycemic control and weight loss, often reducing the need for other diabetes medications and potentially slowing disease progression.

5

Prediabetes or insulin resistance

In those with prediabetes or insulin resistance, semaglutide may help prevent progression to diabetes while supporting weight management goals that are critical for metabolic health.

6

Cardiovascular risk factors

Weight loss achieved with semaglutide is often accompanied by improvements in cardiovascular risk factors including blood pressure, cholesterol profiles, and inflammatory markers, potentially reducing overall cardiac risk.

How Semaglutide Works

Semaglutide is a synthetic analog of the natural hormone GLP-1 (glucagon-like peptide-1), which is normally released after eating. The medication works through multiple complementary mechanisms. In the brain, semaglutide acts on appetite centers to reduce hunger signals and increase feelings of fullness or satiety. In the digestive system, it slows gastric emptying, helping you feel full longer after meals. It also affects insulin and glucagon release to regulate blood sugar levels. These combined effects typically lead to reduced food intake, increased satisfaction from smaller meals, and gradual, sustainable weight loss for most patients.

Semaglutide - How It Works

How It Works in Your Body

Activates GLP-1 receptors in brain appetite centers
Delays gastric emptying, prolonging feelings of fullness
Enhances glucose-dependent insulin secretion
Reduces inappropriate glucagon release
May increase resting energy expenditure
Potentially reduces food cravings and reward-driven eating

Explore Our Programs

Discover more specialized treatments and services offered at Fountain

Frequently Asked Questions

Everything you need to know about Semaglutide treatment

Clinical trials show average weight loss of approximately 15–20% of body weight over one year at the 2.4mg dose used for weight management. Individual results vary based on many factors including diet, physical activity, genetics, and adherence to the protocol.
The most common side effects are gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation. These typically improve over time as your body adjusts to the medication and are minimized by the gradual dose escalation schedule. Serious side effects are rare but will be thoroughly discussed during your consultation.
Some weight regain is common if the medication is discontinued, typically around 2/3 of lost weight over time. This is why semaglutide is generally considered a long-term treatment for chronic conditions like obesity, similar to how hypertension or diabetes medications are used long-term.
Coverage varies significantly by insurance provider and plan. Some plans cover semaglutide for diabetes management but may have different policies for weight management. Our team can help navigate insurance options and alternatives if needed.
Clinical trials of semaglutide have shown greater average weight loss compared to other currently available weight loss medications, with results showing approximately twice the weight loss of older medications. Its once-weekly dosing schedule makes it convenient and manageable for many patients.

Ready to Transform Your Weight Management Journey?

Shopping Cart (0)

Your cart is empty

Continue browsing our treatment programs and complete the questionnaires to check your eligibility for treatments.